SCHEMBL14933337

SCHEMBL14933337

O=c1c2ccccc2c2cc(-c3ccccc3)ccc2n1-c1ccc(-c2ccc(-n3c4ccccc4c4ccccc43)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.51
MAPK1 P28482 1/20 0.50
KDM4E B2RXH2 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ATM Q13315 1/20 0.49
NPSR1 Q6W5P4 2/20 0.45
TSPO P30536 1/20 0.43
HDAC4 P56524 1/20 0.43
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
POLB P06746 1/20 0.42
TSHR P16473 1/20 0.42
BRCA1 P38398 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MAPT P10636 4/20 0.42
LMNA P02545 1/20 0.42
HSP90AA1 P07900 1/20 0.42
PGR P06401 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14933375 1.00 KMT2A (0.51) KMT2AMAPK1KDM4EL3MBTL1ATM
SCHEMBL15999707 0.99 KMT2A (0.54) KMT2AMAPK1KDM4EL3MBTL1ATM
SCHEMBL15999725 0.97 KMT2A (0.49) KMT2AMAPK1KDM4EL3MBTL1ATM
SCHEMBL14933461 0.97 MAPK1 (0.54) KMT2AMAPK1KDM4EL3MBTL1ATM
SCHEMBL16002571 0.97 MAPK1 (0.54) KMT2AMAPK1KDM4EL3MBTL1ATM
SCHEMBL14933522 0.97 MAPK1 (0.54) KMT2AMAPK1KDM4EL3MBTL1ATM
SCHEMBL14933457 0.97 MAPK1 (0.54) KMT2AMAPK1KDM4EL3MBTL1ATM
SCHEMBL14933338 0.97 MAPK1 (0.49) KMT2AMAPK1KDM4EL3MBTL1ATM
SCHEMBL15999770 0.96 KMT2A (0.51) KMT2AMAPK1KDM4EL3MBTL1ATM
SCHEMBL14933453 0.96 KMT2A (0.51) KMT2AMAPK1KDM4EL3MBTL1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649213-B1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2021-06-23 EP disclosed
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-09 US disclosed
WO-2019007867-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-01-10 WO disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
EP-2773721-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2015-11-25 EP disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
WO-2013064206-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2013-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO4C1, SLCO2A1 KMT2A 3888/4885MAPK1 4607/4885KDM4E 3376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.